about
Circulating MicroRNAs as Biomarkers in Biliary Tract CancersMicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentMicroRNAs and benign biliary tract diseasesFunction and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseNeonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and TreatmentDifferential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.MicroRNAs in liver diseaseMicroRNAs in Cholangiopathies.Noninvasive micromarkersDynamic recruitment of microRNAs to their mRNA targets in the regenerating liverSerum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresiaCirculating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease.Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in RatsBiliary atresia: Where do we stand now?Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets.Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.Etiology of biliary atresia as a developmental anomaly: recent advances.Human RNAi pathway: crosstalk with organelles and cells.Recent Advances in Etiology of Biliary Atresia.Metabonomics reveals metabolite changes in biliary atresia infants.An integrated analysis of differential miRNA and mRNA expressions in human gallstones.Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases.Recent advances in pediatric gastroenterology, hepatology and nutrition.Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.Development and Validation of Novel Diagnostic Models for Biliary Atresia in a Large Cohort of Chinese Patients
P2860
Q26746000-C8185774-27F4-484C-BC44-0511A1AD00BAQ26783579-7ACA2316-35AE-4CA1-B047-CE9B59C783C9Q26865762-1E1EAD88-FCF2-4A1F-822A-8436B86876A4Q28073703-15A557F7-FA0D-4E27-8357-C7C1A2D9887CQ28083869-C6C0DA9C-6A11-465C-A476-16DFC8867BFDQ33649970-FA40F6F1-F72D-4E29-839B-1392C34BA266Q33880442-11409ED8-C1A0-4BF8-AC73-498D7FEDB8F5Q33991899-4A39CFE9-0246-46AB-A907-5E10D56A8738Q34111606-FB1D1B01-4030-4B45-91E4-C1BBB5B508E8Q34676898-30F44F6F-740F-4177-B9C3-3B23B4BD0338Q36583210-737CC00A-6EAA-4E7F-9DAD-27CA52355CD0Q36735346-77DB95BE-9607-4C9E-9FB6-3FB671BC7B48Q37228567-F6F16955-184C-4D7E-BBF2-B791C265708CQ37539650-4824E555-9DB7-48FB-BD84-63C40103ABD1Q37599098-DA9E21EF-AA58-4F7D-959F-901E13AE938DQ37619724-327C8B5E-AD5B-4EEA-8F7E-7F11961BD0D6Q38097316-C47B5B90-EDE8-4BFB-B548-5C7FDCB7736BQ38160374-38A9ED11-3AEA-4535-94E9-B434C2069A47Q38245985-89FFA6C4-2B5F-43E0-B4E4-BEBBC3EE5E80Q41300611-77A470CF-7D61-4B81-B3A5-3C9C07538698Q41499011-6D501CD2-59FF-4A57-96F3-B8B199A06C1EQ41673524-B52EE971-4328-4AD7-864E-9225647E67E5Q43105339-00866776-0ED1-4243-B7A8-E9A3D6B9F072Q48250842-96CA7001-67E2-4778-9395-AA81035F82FEQ57171998-FDA21055-A1D1-4F91-914F-8ADD6268B163
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Circulating microRNA is a biomarker of biliary atresia.
@en
Circulating microRNA is a biomarker of biliary atresia.
@nl
type
label
Circulating microRNA is a biomarker of biliary atresia.
@en
Circulating microRNA is a biomarker of biliary atresia.
@nl
prefLabel
Circulating microRNA is a biomarker of biliary atresia.
@en
Circulating microRNA is a biomarker of biliary atresia.
@nl
P2093
P2860
P1476
Circulating microRNA is a biomarker of biliary atresia.
@en
P2093
Adam M Zahm
Joshua R Friedman
LaTasha A Boateng
Nicholas J Hand
P2860
P304
P356
10.1097/MPG.0B013E318264E648
P407
P577
2012-10-01T00:00:00Z